We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Epigenetic regulation of pulmonary inflammation
Summary
Researchers reviewed how environmental exposures drive epigenetic changes — including DNA methylation, histone modifications, and non-coding RNA transfers via extracellular vesicles — that promote chronic lung diseases such as COPD, asthma, and pulmonary fibrosis, while also identifying these same epigenetic pathways as promising therapeutic targets.
Pulmonary disease such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis and pulmonary hypertension are the leading cause of deaths. More importantly, lung diseases are on the rise and environmental factors induced epigenetic modifications are major players on this increased prevalence. It has been reported that dysregulation of genes involved in epigenetic regulation such as the histone deacetylase (HDACs) and histone acetyltransferase (HATs) play important role in lung health and pulmonary disease pathogenesis. Inflammation is an essential component of respiratory diseases. Injury and inflammation trigger release of extracellular vesicles that can act as epigenetic modifiers through transfer of epigenetic regulators such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), proteins and lipids, from one cell to another. The immune dysregulations caused by the cargo contents are important contributors of respiratory disease pathogenesis. N6 methylation of RNA is also emerging to be a critical mechanism of epigenetic alteration and upregulation of immune responses to environmental stressors. Epigenetic changes such as DNA methylation are stable and often long term and cause onset of chronic lung conditions. These epigenetic pathways are also being utilized for therapeutic intervention in several lung conditions.
Sign in to start a discussion.
More Papers Like This
Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health
This review examines how breathing in particulate matter from air pollution -- which can include microplastic particles -- causes lasting health damage through epigenetic changes, meaning it alters how genes are turned on and off without changing the DNA itself. These changes have been linked to cancer, lung scarring, brain diseases, and metabolic disorders. The findings suggest that airborne microplastics could contribute to disease through similar epigenetic mechanisms.
Exposure to environmental xenobiotics and lung tissue function: A comprehensive review on biological mechanisms and pathways
This comprehensive review examines how environmental pollutants including microplastics, heavy metals, and volatile organic compounds damage lung tissue through mechanisms like oxidative stress, inflammation, and disruption of cellular barriers. The study suggests these pollutants contribute to chronic respiratory diseases and highlights how they can also cause epigenetic changes that may affect future generations.
Microplastics as environmental modifiers of lung disease
This review examines growing evidence that inhaled microplastics may contribute to lung diseases including asthma, pulmonary fibrosis, and chronic obstructive pulmonary disease. Researchers found that different plastic types, sizes, and weathering states can trigger inflammation, oxidative stress, and cellular changes in lung tissue, suggesting microplastics may act as environmental modifiers that worsen respiratory conditions.
RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension
Using RNA-seq and ChIP-seq, researchers found that microplastics promote endothelial-to-mesenchymal transition in pulmonary artery cells through a pathway involving HK2-mediated histone lactylation, which contributes to pulmonary hypertension. This epigenetic mechanism provides a new molecular explanation for how microplastic exposure may drive vascular remodeling in the lungs.
Silent invaders: the role of MPs on epithelium inflammation and damage in airway diseases
This review examines how inhaled microplastics and nanoplastics interact with airway epithelial surfaces and trigger inflammatory, oxidative, and structural changes that may contribute to respiratory diseases. The study describes how these particles activate key inflammatory pathways such as NF-kB and PI3K/Akt/mTOR, potentially worsening conditions like asthma and COPD through enhanced barrier dysfunction, oxidative stress, and disrupted tissue repair.